Skip to content
Drug Prices AV Recommends More Clear Disclosures for Medicare Prescription Payment Plan Drug Prices AV Submits Letter on Controlled Clinical Investigation and Confirmatory Evidence Drug Prices AV Submits Letter on Excise Tax on Designated Drugs Drug Prices AV Submits Letter on Decentralized Clinical Trials Drug Prices AV Submits Formal Comments for Proposed Rule on Drug Rebate Program Drug Prices How Policymakers Can Fix Pharmacy Benefit Managers

About Us

We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
Arnold Ventures logo